Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines, antitussives, analgesics, antidepressants, and anti-inflammatory medicines. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 859 Cr
P/E 20.00
Div Yield 0.00 %
Book Value βΉ18.10
52w High βΉ360.00
52w Low βΉ162.00
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Dec 2022
Sep 2022
Jun 2022
Sales
163.00
172.00
133.00
161.00
131.00
139.00
146.00
144.00
146.00
133.00
126.00
124.00
117.00
Expenses
139.00
142.00
120.00
141.00
120.00
121.00
124.00
127.00
133.00
119.00
119.00
118.00
120.00
Operating Profit
24.00
30.00
14.00
20.00
11.00
18.00
21.00
17.00
13.00
14.00
6.00
6.00
-3.00
OPM %
15.00
17.00
10.00
12.00
8.00
13.00
15.00
12.00
9.00
11.00
5.00
4.50
-2.60
Other Income
0.00
2.00
1.00
2.00
1.00
26.00
1.00
1.00
1.00
-3.00
0.00
1.00
2.00
Depreciation
4.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
Interest
8.00
9.00
10.00
10.00
8.00
7.00
8.00
8.00
6.00
8.00
7.00
4.00
3.00
Profit before tax
14.00
19.00
1.00
8.00
1.00
34.00
10.00
7.00
5.00
1.00
-3.00
-1.00
-7.00
Tax %
1.00
-6.00
5.00
2.00
0.00
1.00
0.00
-2.00
6.00
-11.00
8.00
25.00
-3.00
Net Profit
13.00
20.00
1.00
8.00
1.00
34.00
10.00
7.00
5.00
1.00
-3.00
-1.00
-7.00
EPS in Rs
4.10
6.18
0.37
2.45
0.32
10.27
3.14
2.25
1.43
0.31
-1.00
-0.27
-2.21
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015 Sep 2014
Sales
600.00 557.00 485.00 511.00 392.00 367.00 391.00 370.00 432.00 420.00 250.00 661.00
Expenses
520.00 484.00 459.00 475.00 374.00 344.00 375.00 438.00 414.00 387.00 228.00 637.00
Operating Profit
80.00 73.00 26.00 36.00 18.00 23.00 16.00 -68.00 19.00 33.00 21.00 25.00
OPM %
13.00 13.00 5.00 7.00 4.70 6.00 4.10 -18.00 4.30 8.00 9.00 3.70
Other Income
0.00 26.00 -3.00 77.00 2.00 84.00 9.00 76.00 90.00 0.00 6.00 -78.00
Interest
37.00 29.00 21.00 21.00 23.00 33.00 40.00 31.00 36.00 32.00 19.00 48.00
Depreciation
13.00 13.00 12.00 11.00 10.00 10.00 10.00 10.00 10.00 9.00 5.00 23.00
Profit before tax
30.00 56.00 -10.00 81.00 -12.00 65.00 -25.00 -32.00 62.00 -7.00 4.00 -125.00
Tax %
-3.00 1.00 1.00 0.00 2.00 0.00 -1.00 -1.00 1.00 0.00 28.00 2.00
Net Profit
31.00 56.00 -10.00 81.00 -13.00 64.00 -25.00 -32.00 62.00 -7.00 3.00 -128.00
EPS in Rs
9.32 17.09 -3.18 24.94 -5.04 25.79 -10.48 -13.49 26.71 -3.58 1.60 -63.95
Dividend Payout %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015 Sep 2014
Equity Capital
33.00 33.00 33.00 33.00 25.00 25.00 24.00 24.00 23.00 20.00 20.00 20.00
Reserves
26.00 -5.00 -66.00 -56.00 -181.00 -168.00 -233.00 -208.00 -176.00 -209.00 -214.00 -212.00
Borrowings
179.00 116.00 95.00 100.00 192.00 190.00 260.00 250.00 300.00 362.00 381.00 389.00
Other Liabilities
176.00 199.00 241.00 276.00 253.00 232.00 236.00 207.00 265.00 215.00 209.00 209.00
Total Liabilities
414.00 343.00 304.00 353.00 289.00 279.00 286.00 273.00 412.00 388.00 396.00 406.00
Fixed Assets
201.00 167.00 167.00 167.00 167.00 164.00 172.00 178.00 186.00 180.00 164.00 174.00
CWIP
5.00 3.00 2.00 2.00 11.00 14.00 9.00 10.00 10.00 14.00 19.00 13.00
Investments
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
208.00 174.00 135.00 183.00 111.00 101.00 105.00 84.00 216.00 193.00 213.00 219.00
Total Assets
414.00 343.00 304.00 353.00 289.00 279.00 286.00 273.00 412.00 388.00 396.00 406.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015 Sep 2014
Cash from Operating Activity
26.00 4.00 20.00 41.00 17.00 44.00 30.00 32.00 43.00 43.00 40.00 68.00
Cash from Investing Activity
-51.00 -17.00 -9.00 1.00 8.00 64.00 -3.00 -1.00 -13.00 -20.00 -5.00 -6.00
Cash from Financing Activity
26.00 15.00 -32.00 -29.00 -17.00 -108.00 -27.00 -33.00 -27.00 -28.00 -30.00 -71.00
Net Cash Flow
1.00 2.00 -21.00 13.00 7.00 0.00 0.00 -2.00 3.00 -5.00 5.00 -9.00
Free Cash Flow
-23.00 -10.00 7.00 42.00 12.00 36.00 25.00 30.00 29.00 22.00 35.00 56.00
CFO/OP %
33.00 6.00 76.00 113.00 97.00 188.00 188.00 -49.00 234.00 129.00 188.00 278.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015 Sep 2014
Debtor Days
70.00 59.00 52.00 45.00 32.00 50.00 41.00 29.00 71.00 65.00 144.00 57.00
Inventory Days
47.00 43.00 26.00 60.00 41.00 25.00 36.00 27.00 63.00 69.00 103.00 42.00
Days Payable
172.00 196.00 179.00 218.00 221.00 253.00 209.00 174.00 260.00 172.00 301.00 113.00
Cash Conversion Cycle
-55.00 -94.00 -101.00 -113.00 -148.00 -177.00 -131.00 -118.00 -125.00 -38.00 -55.00 -14.00
Working Capital Days
4.00 -40.00 -152.00 -153.00 -251.00 -236.00 -254.00 -277.00 -185.00 -123.00 -140.00 -44.00
ROCE %
37.00 61.00 21.00 46.00 27.00 31.00 26.00 -1.00 57.00 12.00 β 4.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
43.01
43.01
43.08
43.09
39.63
39.76
39.76
39.77
39.79
39.79
39.79
39.80
FIIs
0.89
0.59
0.72
0.82
1.59
1.55
0.84
1.02
0.22
0.18
0.00
0.00
DIIs
0.06
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Public
56.04
56.39
56.21
56.08
58.79
58.68
59.40
59.21
59.97
60.02
60.20
60.19
No. of Shareholders
17,174
16,732
17,261
17,717
17,894
17,889
17,999
17,199
14,400
13,087
11,616
11,634
Corporate Actions
29 records
Back to all stocks